1. Mycolyltransferase is important for biofilm formation and pathogenesis of Tsukamurella keratitis
- Author
-
Jade Lee-Lee Teng, Ying Tang, Samson Sai-Yin Wong, Man Lung Yeung, Jian-Pao Cai, Chen Chen, Elaine Chan, Jordan Yik-Hei Fong, Rex Kwok-Him Au-Yeung, Lifeng Xiong, Terrence Chi-Kong Lau, Susanna Kar-Pui Lau, and Patrick Chiu-Yat Woo
- Subjects
Tsukamurella ,mycolyltransferase ,virulence ,keratitis ,conjunctivitis ,Koch's postulates ,Infectious and parasitic diseases ,RC109-216 ,Microbiology ,QR1-502 - Abstract
Tsukamurella, a group of multi-drug resistant, Gram-positive, aerobic, and partially acid-fast bacteria, are emerging causes of bacterial conjunctivitis and keratitis. However, the pathogenesis of Tsukamurella keratitis is largely unknown. To address this, we used New Zealand White rabbits to develop the first eye infection model and conducted in vitro tests to study the pathogenesis mechanisms of Tsukamurella. There is increasing evidence that biofilms play a significant role in ocular infections, leading us to hypothesize that biofilm formation is crucial for effective Tsukamurella infection. In order to look for potential candidate genes which are important in biofilm formation and Tsukamurella keratitis. We performed genome sequencing of two ocular isolates, T. pulmonis-PW1004 and T. tyrosinosolvens-PW899, to identify potential virulence factors. Through in vitro and in vivo studies, we characterized their biological roles in mediating Tsukamurella keratitis. Our findings confirmed that Tsukamurella is an ocular pathogen by fulfilling Koch's postulates, and using genome sequence data, we identified tmytC, encoding a mycolyltransferase, as a crucial gene in biofilm formation and causing Tsukamurella keratitis in the rabbit model. This is the first report demonstrating the novel role of mycolyltransferase in causing ocular infections. Overall, our findings contribute to a better understanding of Tsukamurella pathogenesis and provide a potential target for treatment. Specific inhibitors targeting TmytC could serve as an effective treatment option for Tsukamurella infections.
- Published
- 2024
- Full Text
- View/download PDF